Multivariate analysis showed that primary therapy outcome (p < 0.001), residual tumor (p = 0.001), ATP1A3 (p = 0.006), and ATP1A4 (p = 0.017) were independent risk factors for DSS (Table 3). The gene discussed is ATP1A3; the disease is neoplasm.